lawsuits against tirzepatide Novo Nordisk filed a lawsuit Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Zepbound Lawsuit [2026 Update] |
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
![lawsuits against tirzepatide Novo Nordisk filed a lawsuit Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Zepbound Lawsuit [2026 Update] |](https://www.robertkinglawfirm.com/wp-content/uploads/2024/11/zepbound-lawsuit-timeline.webp)
![lawsuits against tirzepatide Novo Nordisk filed a lawsuit Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Zepbound Lawsuit [2026 Update] |](https://k2-prod-alm.s3.us-east-1.amazonaws.com/brightspot/0f/aa/2db5a9ed4df38ad760ee815d9481/mounjaro-pens-767x633.jpg)
![lawsuits against tirzepatide Novo Nordisk filed a lawsuit Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Zepbound Lawsuit [2026 Update] |](https://www.reuters.com/resizer/v2/CUCHNSKYUZILPPNWFU225VTSVY.jpg?auth=8fc77d8a0b98246a550ea7f457ecf9f8a5f46c76f3b581cdc3b650983d4217ae&height=2400&width=1920&quality=80&smart=true)
![lawsuits against tirzepatide Novo Nordisk filed a lawsuit Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Zepbound Lawsuit [2026 Update] |](https://cardiovascularbusiness.com/sites/default/files/2023-11/screen_shot_2023-11-08_at_2.23.16_pm.png)
![lawsuits against tirzepatide Novo Nordisk filed a lawsuit Eli Lilly & Co. accusing the manufacturer of weight-loss drug Zepbound of deceptive advertising for allegedly comparing high doses of its drug to low doses of Zepbound Lawsuit [2026 Update] |](https://npr.brightspotcdn.com/dims3/default/strip/false/crop/1024x576+0+54/resize/1400/quality/85/format/jpeg/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2Fd5%2F8a%2F7cfce9bb410991e71e38501c9328%2Fgettyimages-2126120280.jpg)























